Recent studies show that HIV patients are 10 to 20 times more likely to develop lymphoma compared to individuals without HIV.

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

8 However, we now describe a lymphoma harboring a CAR transgene integration ... degree of suspicion with otherwise unexplained clinical symptoms that are consistent with T-cell infiltration ...

Lauren Juyia, a gynaecologist who survived stage 4 colon cancer, has shared three of the symptoms she spotted before she was ...

Bristol Myers Squibb said it has received positive results for its latest lymphoma treatment trials, the fifth type of cancer the drug has been shown to treat.

Fraser Wood, 7, was diagnosed with a type of blood cancer known as lymphoblastic lymphoma after becoming ill over the summer ...

On World Cancer Day 2025, recognise the importance of early detection. Here are eight symptoms that may indicate cancer and ...